Analysts Set Cardinal Health, Inc. (NYSE:CAH) PT at $165.93

Cardinal Health, Inc. (NYSE:CAH) has been given an average rating of “Moderate Buy” by the fifteen research firms that are currently covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $165.9333.

CAH has been the subject of a number of recent research reports. Jefferies Financial Group set a $150.00 price target on shares of Cardinal Health in a report on Tuesday, August 12th. Wells Fargo & Company reiterated an “overweight” rating and set a $185.00 price target (up from $183.00) on shares of Cardinal Health in a report on Wednesday, August 13th. Argus set a $189.00 price target on shares of Cardinal Health in a report on Friday, August 22nd. Bank of America lifted their price target on shares of Cardinal Health from $165.00 to $170.00 and gave the stock a “buy” rating in a report on Tuesday, June 10th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a report on Saturday, September 27th.

Cardinal Health Trading Down 2.5%

NYSE:CAH opened at $154.50 on Monday. The firm has a 50-day moving average price of $152.07 and a two-hundred day moving average price of $150.25. Cardinal Health has a twelve month low of $106.98 and a twelve month high of $168.44. The company has a market capitalization of $36.71 billion, a P/E ratio of 23.95, a price-to-earnings-growth ratio of 1.34 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last posted its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same period last year, the firm posted $1.84 EPS. The firm’s revenue for the quarter was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities research analysts predict that Cardinal Health will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a $0.5107 dividend. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. Cardinal Health’s dividend payout ratio (DPR) is currently 31.63%.

Insiders Place Their Bets

In related news, insider Jessica L. Mayer sold 38,078 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the sale, the insider directly owned 48,457 shares of the company’s stock, valued at approximately $7,211,370.74. This trade represents a 44.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Stephen M. Mason sold 41,575 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer directly owned 26,085 shares in the company, valued at $3,881,969.70. This represents a 61.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Cardinal Health

Several hedge funds have recently modified their holdings of the stock. Geode Capital Management LLC boosted its position in shares of Cardinal Health by 3.3% in the second quarter. Geode Capital Management LLC now owns 6,389,049 shares of the company’s stock worth $1,069,005,000 after acquiring an additional 205,539 shares during the last quarter. JPMorgan Chase & Co. lifted its position in Cardinal Health by 40.0% during the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after buying an additional 1,193,983 shares in the last quarter. Norges Bank acquired a new position in Cardinal Health during the second quarter valued at approximately $584,420,000. Northern Trust Corp lifted its position in Cardinal Health by 3.5% during the first quarter. Northern Trust Corp now owns 3,143,003 shares of the company’s stock valued at $433,012,000 after buying an additional 105,154 shares in the last quarter. Finally, Invesco Ltd. lifted its position in Cardinal Health by 7.3% during the second quarter. Invesco Ltd. now owns 3,037,782 shares of the company’s stock valued at $510,347,000 after buying an additional 207,750 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.